Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited)

v3.21.1
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Common stock
Additional paid-in capital
Accumulated deficit
Total
Balances at Dec. 31, 2019 $ 579 $ 7,391 $ 19,712,115 $ (12,794,473) $ 6,925,612
Balances (in Shares) at Dec. 31, 2019 578,567 7,390,261      
Conversion of Series A Convertible Preferred Stock into common stock $ (68) $ 178 (110)    
Conversion of Series A Convertible Preferred Stock into common stock (in Shares) (67,500) 177,633      
Shares issued to a current and former employee   $ 67 367,533   367,600
Shares issued to a current and former employee (in Shares)   66,667      
Shares issued for equity financing        
Net Loss       (1,149,651) (1,149,651)
Balances at Mar. 31, 2020 $ 511 $ 7,636 20,079,538 (13,944,124) 6,143,561
Balances (in Shares) at Mar. 31, 2020 511,067 7,634,561      
Balances at Dec. 31, 2020 $ 85 $ 9,896 25,920,858 (20,196,823) 5,734,016
Balances (in Shares) at Dec. 31, 2020 84,872 9,895,600      
Conversion of Series A Convertible Preferred Stock into common stock $ (20) $ 53 (33)    
Conversion of Series A Convertible Preferred Stock into common stock (in Shares) (20,000) 72,369      
Shares issued for vested restricted stock units   $ 9 (9)    
Shares issued for vested restricted stock units (in Shares)   8,832      
Stock based compensation     500,718   500,718
Shares issued for equity financing   $ 72 249,928   250,000
Shares issued for equity financing (in Shares)   52,632      
Net Loss       (747,943) (747,943)
Balances at Mar. 31, 2021 $ 65 $ 10,030 $ 26,671,462 $ (20,944,766) $ 5,736,791
Balances (in Shares) at Mar. 31, 2021 64,872 10,029,433